O besity in childhood has increased dramatically in the last decades; so have the risks of associated medical conditions, such as type 2 diabetes and cardiovascular disease (1, 2) . Because obesity is a multifactorial syndrome influenced by genetic, epigenetic, environmental, and behavioral factors (3, 4) and is often resistant to therapy, early prevention efforts are requested. Therefore, the identification of new early biomarkers of susceptibility is relevant to intervene with lifestyle and nutritional changes before the disease is manifested. In this sense, one of the objectives of the IDEFICS (Identification and Prevention of Dietary-and Lifestyle-Induced Health Effects in Children and Infants Project) is to identify biomarkers of susceptibility and their association with the development of overweight/obesity and metabolic syndrome in European children (5, 6) .
Previous studies in rats have pointed out the use of blood cells as a robust model to study energy homeostasis maintenance and its relationship with body weight control (7) (8) (9) , thus providing a potential tissue source to discover novel biomarkers related with energy balance. The use of blood cells for gene expression studies offers an advantage over other human tissues because they are the most readily accessible tissue and are therefore of great interest for clinical studies and experimental research (7, 10) .
Thus, the objective of this study was to evaluate, in blood samples of a subsample of normal-weight and overweight children from the IDEFICS population, whether the expression levels of selected genes involved in energy homeostasis (LEPR, INSR, CPT1A, SLC27A2, UCP2, FASN, and PPAR␣) are altered in the obese state, to identify potential markers of overweight development in children. Additionally, we sought to evaluate whether expression levels of these genes are related with the insulin-resistant or dyslipidemic state associated with overweight.
Subjects and Methods

Subjects
IDEFICS is a large European multicenter study on childhood obesity. Details of the general design and baseline survey characteristics can be found elsewhere (11) .
Subjects involved in this study were a subset of 306 children, selected from those enrolled in the baseline survey (that included more than 16,000 children). The subjects included were both males and females, with normal weight and overweight, and belonging to eight European countries geographically spread across Europe: Germany (n ϭ 40), Hungary (n ϭ 29), Italy (n ϭ 43), Cyprus (n ϭ 41), Spain (n ϭ 37), Estonia (n ϭ 37), Sweden (n ϭ 45), and Belgium (n ϭ 34). In all countries, approval from the local ethical committees and parental consent was obtained.
Anthropometric measurements and biochemical measurements
Children in the IDEFICS baseline survey participated in a standardized physical examination. Collected anthropometric data included body weight and height, waist and hip circumference, and skin fold thickness measurement (at four body sites: subscapular, biceps, triceps, and suprailiac). The body mass index (BMI) was calculated as weight (kilograms) divided by height (meters) squared according to International Obesity Task Force criteria (12) . Details on the biological samples collected during the IDEFICS survey have been described elsewhere in detail (13) .
Blood sampling and processing for gene expression analysis
For each participant, a total of 2.5 ml peripheral blood was collected under fasting conditions into PAXgene vacutainer tubes (QIAGEN, Hilden, Germany) via antecubital fossa venipuncture, following the manufacturer's instructions (QIAGEN). Total RNA was isolated using the PAXgene blood RNA kit according to the manufacturer's instructions (QIAGEN). RNA quality and purity were analyzed by spectrophotometry using the Nanodrop ND-1000, and RNA integrity was confirmed using agarose gel electrophoresis.
Real-time quantitative RT-PCR analysis
All primers were obtained from Sigma Genosys (Sigma-Aldrich Quimica SA, Madrid, Spain). Quantitative RT-PCR was performed as previously described (14) .
The threshold cycle (Ct) was calculated using the instrument's software (StepOne Software version 2.0), and the relative expression ratio of a target gene was calculated based on the corresponding real-time PCR efficiency and Ct deviation of an unknown sample vs. mean Ct of all samples and expressed in comparison to a reference gene (15) . Rplpo was chosen as reference gene because it has been validated for human studies (16) .
Statistical analysis
ANOVA was used to determine differences between normalweight and overweight children and other factors (such as sex, country, and gene expression category) with age as covariate. No interaction between country and the other factors studied was found.
Single differences between two groups were assessed by Student's t test. The association between BMI and gene expression in total blood cells was assessed by age-adjusted partial correlation analysis (first order). The median value of the distribution in the overall group was selected as an arbitrary cut point to define gene expression categories (subjects with a low or high expression of LEPR, INSR, CPT1A, SLC27A2, FASN, and PPAR␣).
All the analyses were performed using SPSS version 18 for Windows (SPSS, Chicago, IL). Threshold of significance was defined at P Ͻ 0.05.
Results
Characteristics of study subjects
A summary of the subject information is shown in Table 1 . Of the 306 children enrolled in the study, 274 subjects were fully characterized. Weight categories were defined according to Cole et al. (12) . Of note, despite being very young, overweight children already showed significant differences compared with normal-weight children in parameters tested [higher sc fat, waist, waist to hip ratio, systolic and diastolic blood pressure, and homeostasis model assessment (HOMA) values] as well as exhibited higher circulating concentrations of insulin, glucose, triglycerides, low-density lipoprotein (LDL) cholesterol, and lower high-density lipoprotein cholesterol.
Gene expression levels in total blood cells
Transcript levels of LepR were significantly higher in blood cells from overweight compared with normalweight children (Table 1) . Concerning INSR and CPT1A transcripts, there was an interaction between gender and BMI category (P ϭ 0.092 and 0.027, respectively, by ANOVA); male overweight children presented higher expression levels, whereas no differences were found in female children. The transcript levels of SLC27A2 were lower in both male and female overweight children compared with normal-weight children. Transcript levels of PPAR␣, FASN, and UCP2 were not significantly different between overweight and normal-weight children.
Association studies of gene expression with anthropometric and biochemical parameters of subjects
To examine the potential interaction between gene expression in blood cells and BMI, LDL cholesterol, triglycerides, and HOMA index, subjects were subdivided into categories according to gene expression levels (low vs. high). When subjects were subdivided on the basis of LEPR expression levels, normal-weight children with low expression levels of LEPR exhibited higher levels of LDLcholesterol than normal-weight children with high levels of LEPR transcripts, and similar to those found in overweight children (Fig. 1A) . No significant differences were found concerning LDL cholesterol levels in overweight children in relation to their levels of LEPR transcripts.
Concerning triglyceride levels, overweight children with high expression levels of INSR or CPT1A did not show the increase in triglyceride levels associated with fat Data are presented as mean Ϯ SEM. Statistical analysis, W*S represents the interactive effect between BMI categories and sex (P Ͻ 0.05, two-way ANOVA); S represents the differences between males and females (P Ͻ 0.05, two-way ANOVA); W represents differences between overweight and normal weight (P Ͻ 0.05, two-way ANOVA). All ANOVA were corrected for age. HDL, High-density lipoprotein. a Subcutaneous fat represents the sum of four different skin folds (subscapular, biceps, triceps, and suprailiac).
accumulation (Fig. 1, B and C) , and both normal-weight and overweight children with high expression levels of SLC27A2, FASN, or PPAR␣ exhibited lower triglyceride levels ( Fig. 1, D-F) . Regarding HOMA index, the negative effect of being overweight appears to be attenuated by high CPT1A mRNA levels in male individuals and by high SLC27A2 mRNA levels in both males and females but with a more marked effect in males (Fig. 1, G and H) .
Discussion
For early detection and prevention of overweight-associated diseases, it is necessary to develop new early biomarkers. Blood can be easily obtained from human subjects, and therefore gene expression patterns in blood cells can be easily measured for screening purposes. Here, we focus on the study of the expression of genes related to glucose and lipid metabolism in total blood cells, to discover novel biomarkers related to energy balance in children, because we postulate that blood cell expression pattern may reflect the gene expression profile of key tissues involved in energy metabolism, such as the liver or the adipose tissue, as previously pointed out (7) .
Transcript levels of leptin and insulin receptor were found to be overexpressed in children with overweight, although in the case of INSR, the increase was found only in male children. Concerning LEPR, we found a negative correlation (after correction for confounding factors BMI and age) between the expression levels of LEPR in blood cells and levels of cholesterol (both LDL and total) (partial r ϭ Ϫ0.275 and Ϫ0.216, respectively, P Ͻ 0.01). Noteworthy, normal-weight children with low levels of LEPR transcripts had similar levels of LDL cholesterol as overweight children. Then, independently of BMI, lower expression levels of LEPR in blood cells may reveal high LDL cholesterol levels. With a similar pattern, INSR transcript levels were negatively correlated with triglycerides, after correction for confounding factors BMI and age (partial r ϭ Ϫ0.266, P Ͻ 0.01), and when individuals were classified by high and low INSR expression, we found that those overweight individuals with high expression levels of this gene seem to be protected against the hypertriglyceridemia associated with obesity.
Concerning CPT1A, we found that this gene was overexpressed in males with overweight but not in females. Higher expression levels of CPT1A in blood cells have also been described in diet-induced obese rats (9) , and this gene is also overexpressed in the liver of obese male rats, but not in females (17) . Interestingly, and similarly to results ob- ; CAT, differences between groups divided by gene expression categories (P Ͻ 0.05, two-way ANOVA); W, differences between overweight and normal-weight (P Ͻ 0.05, twoway ANOVA); *, differences between low and high gene expression within a same BMI group (P Ͻ 0.05, Student's t test). All ANOVA analyses were corrected for age.
tained with INSR, overweight individuals with high expression levels of CPT1A in blood cells seem to be protected against the increase in plasma triglyceride levels associated with body fat accumulation. In addition, we found a negative correlation (after correction for BMI and age) between CPT1A mRNA levels and HOMA index only in male children (partial r ϭ Ϫ0.284, P Ͻ 0.05). Moreover, within overweight males, those with lower expression levels of this gene showed higher HOMA index than those with higher expression levels. Then, CPT1A expression levels in blood cells appear to be a good marker for the insulin-resistant state associated with overweight/ obesity in male children. SLC27A2 expression levels were lower in overweight compared with normal-weight children. The decrease of SLC27A2 expression levels in blood cells in obese children together with the negative correlation coefficients found between the expression of this gene in blood cells and BMI (partial r ϭ Ϫ0.214, P Ͻ 0.01) make this gene a candidate biomarker of obesity/overweight in children. In addition, regardless of body weight, individuals with high mRNA levels of SLC27A2 in blood cells displayed lower triglyceride levels. Moreover, within overweight children, those with lower expression levels of this gene exhibited higher HOMA values than those with higher expression levels. Thus, low expression levels of SLC27A2 (as observed for CPT1A) seem to exacerbate the insulin-resistant state associated with excess fat accumulation, particularly in males.
We did not find differences between normal-weight and overweight children concerning the expression levels of FASN and PPAR␣ in blood cells, but curiously, children with high mRNA levels of these genes in blood cells displayed lower triglyceride levels, regardless of body weight, similarly to what was observed for SLC27A2.
It may be interpreted from the findings of this study that some overweight children may be at an early stage of the pathogenesis of diabetes and dyslipidemia, and the expression levels of specific genes in blood cells could be used as markers of body metabolic status, potentially providing an early warning of future disorders. Further investigation in longitudinal studies will help to determine later consequences of these identified biomarkers.
